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Hypoglycemia induced by hepatocellular carcinoma is not a new phenomenon. Beers
and Morton in 1935,in the American Journal of Cancer Research called it Nadler,
Wolfer-Elliot Syndrome, aptly named after the physicians who first described the
association between HCC and hypoglycemia.1
The incidence of hepatocellular carcinoma presenting as the initial presentation is
extremely rare 2, 3. Hypoglycemia may even be the sole presentation in a HCC patient,
as reported by Jayaprasad N 4, similar to our patient who presented acutely with
hypoglycemic attack. Hypoglycemia usually occurs late as part of a paraneoplastic
phenomenon in HCC, which include hypercholesterolaemia, hypoglycaemia,
hypercalcaemia and erythrocytosis.5 The severity of the hypoglycemia have been
reported to cause hypoglycemic encephalopathy 3 and even sudden death 6.
There are 2 known mechanism which HCC could cause hypoglycemia. The tumor
could be so large and rapidly growing that the liver, being replaced by the tumour, is
unable to satisfy the glucose demand for the tumour and other tissues. This is not the
case for our patient the tumor is affecting the left lateral lobe and his right lobe is
normal and not cirrhotic. The possible mechanism of his hypoglycemia could be due to
the tumor secreting IGF (Insulin-like Growth Factor) 2 , which stimulates IGF 1 and
insulin receptors 2,7. This is proven by his low serum insulin and IGF 1 levels. Yonei Y
et al. in an autopsy reported significantly higher IGF 2 levels in the plasma and the
tumour tissue of HCC patients. 8 Unfortunately, we were not able to test for the IGF 2
levels in the plasma nor the resected specimen.
The treatment in most cases reported are palliation with symptomatic control as they
usually present with advance disease. Thipaporn and colleagues have successfully
achieved symptom control with the administration of high carbohydrate intake and
corticosteroids 9. Steroid stimulates gluconeogenesis therefore reducing risk of
hypoglycemia. Percutaneous ethanol injection 10 and transarterial chemo-embolisation
(TACE) have been used to achieve symptom control by cytoreduction.11 Very few cases
have been successfully treated by resection 2. We are glad to report he was
normoglycemic and symptom free after the resection.
CONCLUSION
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Refractory hypoglycemia as a rare cause of initial presentation in 
previously undiagnosed hepatocellular carcinoma 
Hypoglycemia presenting as the initial and sole presentation in a previously
undiagnosed hepatocellular carcinoma (HCC) is extremely rare. We report of such a
case who was successfully treated with resection.
Literature review was performed using on line public bibliographic database i.e. Pub
Med and MedlinePlus. A search was made to include English Language articles
which reported on hepatocellular carcinoma with hypoglycemia ; it’s incidence,
pathology, presentation and treatment. The literature was then appraised and
discussed.
A 29 years old male presented to us with loss of consciousness and blood glucose
level was detected at 1.3 mmol/L. On further questioning, there was vague abdominal
discomfort with weight loss. Abdominal examination revealed a palpable mass over
the left liver lobe. Contrast enhanced computed tomography demonstrated a left lateral
lobe HCC measuring 17 x 11 x 18 cm. Patient was also found to be Hepatitis B
positive and serum alpha feto protein was 79 257 IU/ml. There were no evidence of
metastatic disease.
Hypoglycemia persisted despite continuous dextrose infusion. Serum insulin and IGF-
1 level sent was low at 0.4 Mu/L and 42 ng/ml respectively. Emergency left lateral
hepatectomy was performed with a segment 6 wedge resection for a lesion discovered
on intra operative ultrasound. Histopathological examination revealed a moderately
differentiated HCC. Post operative was uneventful and hypoglycemia episodes
resolved. He was discharged well.
Case Report
IGF 2 induced hypoglycemia in HCC are rare with only few reported in literature and
even fewer treated successfully by resection. The above case illustrated that
hypoglycemia can be a presentation in HCC albeit rare. Early and appropriate
management is crucial to ensure good overall outcome.
Axial View of the computed 
tomography image of the tumour 
confined to the left lateral lobe as 
evident by it’s position lateral to the 
left hepatic vein  
Coronal View of the large HCC. The 
portal vein, although compressed 
were not thrombosed. 
The resected left lateral lobe with 
the large tumour bivalved.  
